An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer

Authors
Publication date
1 January 2019
Publisher
'Elsevier BV'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Institutional Research Information System University of Turin

      redirect
      oaioai:iris.unito.it:2318/1724214
      Last time updated on 29/11/2020